XML 32 R5.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - CAD ($)
 12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Cash flows from operating activities      
Loss for the year $ (7,393,384) $ (2,683,482) $ (6,875,857)
Items not affecting operating activities:      
Interest income received (254,261) (5,590) (22,270)
Unrealized foreign exchange effect on cash and cash equivalents (173,740) (71,562) 290,504
Items not affecting cash:      
Change in fair value of fair value throught profit or loss investments (122,191) (258,702) 427,022
Commitment to issue shares 0 27,462 66,089
Permanent loss on financial instruments 0 697,675 0
Interest on notes receivable (81,850) (58,342) (53,222)
Accretion interest on receivable (167,718) (72,806) 0
Derivative loss on accounts receivable 0 120,900 0
Share - based payments 1,415,639 943,334 476,424
Deferred income tax recovery (2,489,902) (1,439,332) (3,431,230)
Depreciation 39,344 136,200 150,782
Depletion 2,282,276 2,163,221 1,716,848
Impairment of royalty interest 0 0 3,973,699
Writedown of goodwill 2,709,239 1,518,328 3,047,605
Impairment of receivables 0 0 51,302
Realized (gain) loss on sale of investments (83,345) 287,204 58,360
Gain on acquistion and sale of exploration and evalution assets (1,305,237) (6,834,999) (5,393,305)
(Gain) loss on derecognition and sale of property and equipment (29,766) (10,723) (15,892)
Write-off of exploration and evaluation assets 0 0 56,086
Equity loss in associated companies 994,548 1,295,568 1,062,146
Dilution gain in associated companies (503,543) (982,634) 0
Unrealized foreign exchange (gain) loss 597 (67,249) (466,587)
Shares received from joint venture partners included in exploration recoveries (810,521) (134,738) (115,000)
Changes in non-cash working capital items:      
Receivables 1,908,945 (6,343) 101,200
Prepaid expenses (16,698) 3,848 21,366
Accounts payable and accrued liabilities 172,600 (86,317) 83,056
Advances from joint venture partners 467,544 203,536 (291,350)
Total cash used in operating activities (3,441,424) (5,315,543) (5,082,224)
Cash flows from investing activities      
Acquisition and sale of exploration and evaluation assets, net of option payments received 161,048 3,005,280 5,297,357
Interest received on cash and cash equivalents 86,543 5,590 22,270
Notes receivable (1,405,277) (542,622) (973,236)
Proceeds from sale of fair value through profit and loss investments, net 139,365 130,737 136,263
Proceeds of available-for-sale financial instruments 0 17,375 0
Purchase of investments in associated companies (2,059,631) 0 0
Restricted cash (412,262) (89,402) 0
Purchase and sale of property and equipment, net (24,784) (16,999) 2,403
Reclamation bonds 123,679 171,307 71,964
Total cash provided by (used in) investing activities (3,391,319) 2,681,266 4,557,021
Cash flows from financing activities      
Proceeds received from private placement, net of share issue costs 6,907,228 0 0
Proceeds from exercise of options 85,700 127,800 0
Total cash provided by financing activities 6,992,928 127,800 0
Effect of exchange rate changes on cash and cash equivalents 173,740 71,562 (290,504)
Change in cash and cash equivalents 333,925 (2,434,915) (815,707)
Cash and cash equivalents, beginning 3,199,686 5,634,601 6,450,308
Cash and cash equivalents, ending $ 3,533,611 $ 3,199,686 $ 5,634,601